114 related articles for article (PubMed ID: 2504759)
1. Automated high-performance liquid chromatographic determination of 5-S-cysteinyl-3,4-dihydroxyphenylalanine in urine.
Kågedal B; Källberg M; Arstrand K; Hansson C
J Chromatogr; 1989 Jul; 473(2):359-70. PubMed ID: 2504759
[TBL] [Abstract][Full Text] [Related]
2. Improved solid-phase extraction and liquid chromatography with electrochemical detection of urinary catecholamines and 5-S-L-cysteinyl-L-dopa.
Huang TH; Wall J; Kabra P
J Chromatogr; 1988 Oct; 452():409-18. PubMed ID: 3149647
[TBL] [Abstract][Full Text] [Related]
3. Liquid-chromatographic determination of 5-S-L-cysteinyl-L-dopa with electrochemical detection in urine prepurified with a phenylboronate affinity gel.
Kågedal B; Pettersson A
Clin Chem; 1983 Dec; 29(12):2031-4. PubMed ID: 6416708
[TBL] [Abstract][Full Text] [Related]
4. Determination of urinary 5-S-cysteinyldopa by high-performance liquid chromatography.
Kågedal B; Pettersson A
J Chromatogr; 1983 Feb; 272(2):287-97. PubMed ID: 6403561
[TBL] [Abstract][Full Text] [Related]
5. The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high-pressure liquid chromatography.
Hansson C; Edholm LE; Agrup G; Rorsman H; Rosengren AM; Rosengren E
Clin Chim Acta; 1978 Sep; 88(3):419-27. PubMed ID: 699334
[TBL] [Abstract][Full Text] [Related]
6. [High-performance liquid chromatographic determination of urinary 5-S, 2-S-, 6-S-cysteinyldopa and 2,5-S,S-dicysteinyldopa (author's transl)].
Morishima T; Saito M; Fujita M; Fukada E; Hanawa S
Nihon Hifuka Gakkai Zasshi; 1982 Jan; 92(1):53-6. PubMed ID: 6804671
[No Abstract] [Full Text] [Related]
7. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
Morishima T; Tatsumi F; Fukada E; Saito M; Fujita M; Nagashima N; Hanawa S
Arch Dermatol Res; 1983; 275(2):76-9. PubMed ID: 6409012
[TBL] [Abstract][Full Text] [Related]
8. Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection.
Ito S; Kato T; Maruta K; Fujita K; Kurahashi T
J Chromatogr; 1984 Nov; 311(1):154-9. PubMed ID: 6440898
[No Abstract] [Full Text] [Related]
9. Sensitive high-performance liquid chromatographic method for the determination of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid and 5-S-cysteinyl-3,4-dihydroxyphenylalanine.
Fornstedt-Wallin B; Bergh I
J Chromatogr B Biomed Appl; 1995 Jan; 663(1):9-14. PubMed ID: 7704217
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cysteinyldopas, dopa, dopamine, noradrenaline and adrenaline in serum and urine using high-performance liquid chromatography and electrochemical detection.
Hansson C; Agrup G; Rorsman H; Rosengren AM; Rosengren E; Edholm LE
J Chromatogr; 1979 Jan; 162(1):7-22. PubMed ID: 33194
[TBL] [Abstract][Full Text] [Related]
11. Determination of 5-S-cysteinyldopa in human urine by direct injection in coupled-column high-performance liquid chromatography.
Hansson C; Kågedal B; Källberg M
J Chromatogr; 1987 Sep; 420(1):146-51. PubMed ID: 3117824
[No Abstract] [Full Text] [Related]
12. 5-S-cysteinyldopa in the urine of melanoma patients.
Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
[TBL] [Abstract][Full Text] [Related]
13. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
Stewart RM; Miller S; Gunder M
Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
[TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of 5-S-cysteinyldopa, dopa and dopamine in the urine by means of high-performance liquid chromatography. A comparison with data obtained by means of fluorometry.
Morishima T; Saito M; Hanawa S
J Dermatol; 1981 Aug; 8(4):301-4. PubMed ID: 6795251
[No Abstract] [Full Text] [Related]
15. An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid.
Fornstedt B; Bergh I; Rosengren E; Carlsson A
J Neurochem; 1990 Feb; 54(2):578-86. PubMed ID: 2105377
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 5-S-L-cysteinyl-glycine-L-dopa, a natural substrate for serum and melanocyte dipeptidase.
Kågedal B; Gawelin AL; Pettersson A
Anal Biochem; 1987 Aug; 165(1):167-74. PubMed ID: 3120620
[TBL] [Abstract][Full Text] [Related]
17. [Urinary 5-S-cysteinyldopa in malignant melanoma subjects-with special reference to melanoma stages and dopa loading test (author's transl)].
Ichihasi M; Mojamdar M; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1981 Sep; 91(10):1045-9. PubMed ID: 6798247
[No Abstract] [Full Text] [Related]
18. Urinary free and conjugated 5-S-cysteinyldopa in normal subjects and in patients with melanoma.
Graef V; Paul E
Br J Dermatol; 1982 Jan; 106(1):53-7. PubMed ID: 6800394
[TBL] [Abstract][Full Text] [Related]
19. [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
Paul E; Graef V; Ruppel R; Hellwich M
Z Hautkr; 1983 Feb; 58(4):262-5. PubMed ID: 6405551
[TBL] [Abstract][Full Text] [Related]
20. Isolation of 2-S-cysteinyldopa and 2,5-S,S-dicysteinyldopa from the urine of patients with melanoma.
Prota G; Rorsman H; Rosengren AM; Rosengren E
Experientia; 1977 Jun; 33(6):720-1. PubMed ID: 891724
[No Abstract] [Full Text] [Related]
[Next] [New Search]
